IN
INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH
Grant-FundedCORDISNeurotoxicity De-Risking in Preclinical Drug Discovery
Biotech · SaaS
INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH is a private SME recorded in CORDIS in Austria, with participation in 5 EU research and innovation projects. Its recorded projects include “Neurotoxicity De-Risking in Preclinical Drug Discovery”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€1,168,673
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇦🇹Austria
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH is a private SME recorded in CORDIS in Austria, with participation in 5 EU research and innovation projects. Its recorded projects include “Neurotoxicity De-Risking in Preclinical Drug Discovery”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
BiotechSaaS
Tags:BiotechSaaS
Company Info
INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH Info
Funding
EU Grants€1,168,673